As of 4/10/2026, 11:47:15 AM
Market Cap
13.27B
P/E Ratio (TTM)
22.93
Free Float
-
Volume (30D Avg)
309.61K
1Y Change
-1.99%
Shares Outstanding
88.33M
| Period | Revenue | Profit After Tax | EPS |
|---|---|---|---|
| 2025 | 5.84M | 447,147 | 5.52 |
BF Biosciences Limited ("BFBL", "Company", or the "Issuer") was incorporated as an unlisted public limited company under the Companies Ordinance, 1984 (now Companies Act, 2017) in 2006, and operates within the pharmaceutical industry. BFBL is a 80%:20% joint venture between Ferozsons Laboratories Limited and the Bagó Group of Argentina. The Company's core operations involve the import, manufacturing, marketing and distribution of pharmaceutical products.
197-A, The Mall, Rawalpindi, Pakistan
KPMG Taseer Hadi & Co. Chartered Accountants
CDC Share Registrar Services Limited, CDC House, 99-B, Block-B, S.M.C.H.S, Main Shahrah Faisal, Karachi
June
Chief Executive Officer
Akhter Khalid Waheed
Chairperson
Sebastian Martin Ferrarassi
Company Secretary
Abdur Rehman
Board of Directors
